JW Therapeutics 药明巨诺
Yan Wang, M.D., Ph.D. currently serves as the VP, Head of Business Development, Alliance Management, and Corporate Strategy at JW Therapeutics, a biotechnology company specializing in cell immunotherapy products. Prior to this role, Yan worked in various business development positions at IASO BioTherapeutics, IASO BIO USA, Simcere Pharmaceutical Group, and Adaptimmune. With a background in immunology and pharmacology, Yan has contributed significantly to the development and commercialization of innovative therapies for oncology.
This person is not in any teams
This person is not in any offices
JW Therapeutics 药明巨诺
JW Therapeutics is an innovative biotech company focusing on the latest clinical cell therapy technology. It is commited to the development, transformation and promotion of breakthrough cell-based immunotherapies to save the lives of cancer patients, improve their quality of life and bring new hope. JW Therapeutics was co-founded by WuXi AppTec, Juno Therapeutics in February 2016.